| 2 | Combined burden and functional impact tests for cancer driver discovery using DriverPower. (Shuai S, PCAWG Drivers and Functional Interpretation Working Group, Gallinger S, Stein LD, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):734 25 Citations |
| 1 | The effect of phenotypic outliers and non-normality on rare-variant association testing. (Auer PL, Reiner AP, Leal SM) Eur J Hum Genet 2016 Aug;24(8):1188-94 26 Citations |
| 1 | KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. (Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, Wheler JJ, Luthra R, Naing A, Wang X, Kurzrock R) PLoS One 2012;7(5):e38033 45 Citations |
